Drug
Ferrosoferric Oxide clinical trials
Also written Ferumoxytol and Feraheme.
Includes 2 studies of Ferumoxides.
- studies test it
- 80
- open now
- 13
- in phase 3
- 17
- first study started
- 2004
Keep track of what changes. Save the Ferrosoferric Oxide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
80 studies that test it; most in 2011 (7)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2006 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 7 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 6 |
| 2015 | 6 |
| 2016 | 3 |
| 2017 | 7 |
| 2018 | 6 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 12
- Phase 1
- 15
- Phase 2
- 18
- Phase 3
- 17
- Phase 4
- 10
- No phase
- 12
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 65
AMAG Pharmaceuticals, Inc. (13) · OHSU Knight Cancer Institute (13) · Stanford University (3) · Auerbach Hematology Oncology Associates P C (3) · University of Pennsylvania (3) · Brigham and Women's Hospital (2) · M.D. Anderson Cancer Center (2) · National Cancer Institute (NCI) (2)
Often tested with
Tested in the same studies.
Ferrous sulfate (3) · Gadolinium (3) · Pembrolizumab (2) · Temozolomide (1) · Gadofosveset trisodium (1) · Irinotecan sucrosofate (1) · Hydrogen Peroxide (1) · Saline Solution (1)
Studies
Open first, then newest update. How each study uses Ferrosoferric Oxide is read from its arms, and is right about nine times in ten.
Testing it · 80
- Nanozymes in EndodonticsEnrolling by invitationPhase 4University of PennsylvaniaNCT07518901Written as Nanozyme treatment
- Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous SystemRecruitingPhase 2OHSU Knight Cancer InstituteNCT03270059Written as Ferumoxytol
- Calculating Wall Shear Stress in Infant Pulmonary VeinsRecruitingPhase 1Children's Hospital of PhiladelphiaNCT06440408Written as Ferumoxytol
- Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection FractionRecruitingEarly Phase 1University of FloridaNCT07634640Written as Ferumoxytol infusion
- Enhanced MRI Imaging in Healthy Participants and Participants With EpilepsyRecruitingPhase 2University of AlbertaNCT06483061Written as Ferumoxytol
- A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)RecruitingPhase 3AMAG Pharmaceuticals, Inc.NCT03619850Written as Ferumoxytol
- A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric SubjectsRecruitingPhase 3AMAG Pharmaceuticals, Inc.NCT03893045Written as ferumoxytol
- Ferumoxytol-enhanced Magnetic Resonance Venography in Patients With Venous DiseasesRecruitingPhase 2Min ZhouNCT07452250Written as Ferumoxytol injection
- Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma PatientsRecruitingPhase 3Jonsson Comprehensive Cancer CenterNCT07461948Written as Ferumoxytol
- Virtual Histology of the Bladder Wall for Bladder Cancer StagingRecruitingEarly Phase 1Jodi MaranchieNCT04369560Written as Ferumoxytol intravesical administration (5 mM)
- Early Antenatal Support for Iron Deficiency AnemiaRecruitingPhase 4Thomas Jefferson UniversityNCT04278651Written as Ferumoxytol
- Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical PatientRecruitingPhase 3Auerbach Hematology Oncology Associates P CNCT04268849Written as Ferumoxytol
- IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine BleedingRecruitingPhase 4Thomas Jefferson UniversityNCT04205266Written as Ferumoxytol
- In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance ImagingCompletedPhase 1National Institute of Neurological Disorders and Stroke (NINDS)NCT02511028Written as Ferumoxytol
- Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With CancerCompletedPhase 1/2Stanford UniversityNCT01542879Written as Ferumoxytol
- Novel Imaging Markers in SPMSCompletedEarly Phase 1University of UtahNCT05357833Written as Ferumoxytol infusion
- Predicting Stroke Risk in ICAD With Novel MRIWithdrawnPhase 4Northwestern UniversityNCT05515874Written as Feraheme
- A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in GlioblastomaActive, not recruitingPhase 1Bryan AllenNCT04900792Written as Ferumoxytol injection
- Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency AnemiaCompletedPhase 3Stanford UniversityNCT04253626Written as Ferumoxytol Injection [Feraheme]
- Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)CompletedPhase 2AMAG Pharmaceuticals, Inc.NCT00707876Written as ferumoxytol
See all 80 studies that test Ferrosoferric Oxide →
Given in every arm · 4 — Ferrosoferric Oxide is usual care beside what is tested
- Feasibility of FMISO in Brain TumorsRecruitingPhase 2OHSU Knight Cancer InstituteNCT03649880Written as Ferumoxytol
- Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm InfantsRecruitingPhase 2University of WashingtonNCT05340465Written as Ferumoxytol injection
- Liposomal Irinotecan and Veliparib in Treating Patients With Solid TumorsCompletedPhase 1National Cancer Institute (NCI)NCT02631733Written as Ferumoxytol
- Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRICompletedNot applicableDanish Headache CenterNCT02549898Written as Feraheme
Codes
What other systems call Ferrosoferric Oxide · ClinicalTrials.gg INT008874
- MeSH (NLM) D052203Ferrosoferric OxideConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) XM0M87F357FERROSOFERRIC OXIDEConfirmed FDA, NLM
- RxNorm 1310708One source FDA
- NCI Thesaurus C38138Ferrosoferric OxideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D052203 | Ferrosoferric Oxide | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | XM0M87F357 | FERROSOFERRIC OXIDE | Confirmed FDA, NLM |
| RxNorm | 1310708 | — | One source FDA |
| NCI Thesaurus | C38138 | Ferrosoferric Oxide | One source FDA |
Also registered as ferumoxytol (UNII R8DG7T2D3A) and ferumoxytol non-stoichiometric magnetite (UNII CLH5FT6412 · RxNorm 473387).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.